Evidence map›Paper›PMID 37668619›Full record

Trial reportJAMA2023

Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial.

Hyo Suk Nam, Young Dae Kim, JoonNyung Heo, Hyungwoo Lee, Jae Wook Jung, Jin Kyo Choi, Il Hyung Lee, In Hwan Lim, Soon-Ho Hong, Minyoul Baik and 34 more

2 registry-linked trialsOpen access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 90 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 8 pooled it
32.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04205305 phase4completednot on this map

Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)

TypeinterventionalSponsorYonsei UniversityRan2020 to 2023Enrolled306ConditionsIschemic StrokeArmsconventional blood pressure control (labetalol, nicardipine), intensive blood pressure control (labetalol, nicardipine)
NCT07527013 phase3not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Stratified Blood Pressure Management After Endovascular Treatment for Acute Ischemic Stroke (RESCUE-BP)

TypeinterventionalSponsorBeijing Tiantan HospitalRan2026 to 2028Enrolled544ConditionsEndovascular Therapy, Acute Ischaemic Stroke, Collateral Circulation, Blood Pressure ManagementArmsStratified Blood Pressure Management
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 8 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Blood pressure targets after successful reperfusion in mechanical thrombectomy for acute ischemic stroke: an updated systematic review and meta-analysis of randomized clinical trials.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Association of intensive blood pressure lowering with health-related quality of life after endovascular thrombectomy: a post-hoc analysis of the ENCHANTED2/MT trial.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Systolic blood pressure targets after successful endovascular thrombectomy: a network meta-analysis of randomized controlled trials.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 15 institutions in 3 countries.

Hyo Suk NamDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Young Dae KimDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
JoonNyung HeoDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Hyungwoo LeeDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Jae Wook JungDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Jin Kyo ChoiDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Il Hyung LeeDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
In Hwan LimDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Soon-Ho HongDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Minyoul BaikDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Byung Moon KimDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea.
Dong Joon KimDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea.
Na-Young ShinDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea.
Bang-Hoon ChoDepartment of Neurology, Korea University Anam Hospital and College of Medicine, Seoul, Korea.
Seong Hwan AhnDepartment of Neurology, Chosun University School of Medicine, Gwangju, Korea.
Hyungjong ParkDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea.
Sung-Il SohnDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea.
Jeong-Ho HongDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea.
Tae-Jin SongDepartment of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
Yoonkyung ChangDepartment of Neurology, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
Gyu Sik KimDepartment of Neurology, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.
Kwon-Duk SeoDepartment of Neurology, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.
Kijeong LeeDepartment of Neurology, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.
Jun Young ChangDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jung Hwa SeoDepartment of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Sukyoon LeeDepartment of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Jang-Hyun BaekDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Han-Jin ChoDepartment of Neurology, Pusan National University School of Medicine, Busan, Korea.
Dong Hoon ShinDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea.
Jinkwon KimDepartment of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Joonsang YooDepartment of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Kyung-Yul LeeDepartment of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Yo Han JungDepartment of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Yang-Ha HwangDepartment of Neurology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
Chi Kyung KimDepartment of Neurology, Korea University Guro Hospital and College of Medicine, Seoul, Korea.
Jae Guk KimDepartment of Neurology, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.
Chan Joo LeeDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Sungha ParkIntegrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Division of Cardiology, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
Hye Sun LeeDepartment of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea.
Sun U KwonDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Oh Young BangDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Craig S AndersonThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Ji Hoe HeoDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea.
OPTIMAL-BP Trial Investigators
Yonsei University · KROptimal Solutions (United States) · USKeimyung University · KREwha Womans University · KRInje University Busan Paik Hospital · KRKorea University Medical Center · KRNational Health Insurance Service Ilsan Hospital · KRUlsan College · KRChosun University · KRGachon University Gil Medical Center · KRKangbuk Samsung Hospital · KRKyungpook National University Hospital · KRPusan National University · KRSamsung Medical Center · KRUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Optimal blood pressure (BP) control after successful reperfusion with endovascular thrombectomy (EVT) for patients with acute ischemic stroke is unclear. Objective: To determine whether intensive BP management during the first 24 hours after successful reperfusion leads to better clinical outcomes than conventional BP management in patients who underwent EVT. Design, Setting, and Participants: Multicenter, randomized, open-label trial with a blinded end-point evaluation, conducted across 19 stroke centers in South Korea from June 2020 to November 2022 (final follow-up, March 8, 2023). It included 306 patients with large vessel occlusion acute ischemic stroke treated with EVT and with a modified Thrombolysis in Cerebral Infarction score of 2b or greater (partial or complete reperfusion). Interventions: Participants were randomly assigned to receive intensive BP management (systolic BP target <140 mm Hg; n = 155) or conventional management (systolic BP target 140-180 mm Hg; n = 150) for 24 hours after enrollment. Main Outcomes and Measures: The primary outcome was functional independence at 3 months (modified Rankin Scale score of 0-2). The primary safety outcomes were symptomatic intracerebral hemorrhage within 36 hours and death related to the index stroke within 3 months. Results: The trial was terminated early based on the recommendation of the data and safety monitoring board, which noted safety concerns. Among 306 randomized patients, 305 were confirmed eligible and 302 (99.0%) completed the trial (mean age, 73.0 years; 122 women [40.4%]). The intensive management group had a lower proportion achieving functional independence (39.4%) than the conventional management group (54.4%), with a significant risk difference (-15.1% [95% CI, -26.2% to -3.9%]) and adjusted odds ratio (0.56 [95% CI, 0.33-0.96]; P = .03). Rates of symptomatic intracerebral hemorrhage were 9.0% in the intensive group and 8.1% in the conventional group (risk difference, 1.0% [95% CI, -5.3% to 7.3%]; adjusted odds ratio, 1.10 [95% CI, 0.48-2.53]; P = .82). Death related to the index stroke within 3 months occurred in 7.7% of the intensive group and 5.4% of the conventional group (risk difference, 2.3% [95% CI, -3.3% to 7.9%]; adjusted odds ratio, 1.73 [95% CI, 0.61-4.92]; P = .31). Conclusions and Relevance: Among patients who achieved successful reperfusion with EVT for acute ischemic stroke with large vessel occlusion, intensive BP management for 24 hours led to a lower likelihood of functional independence at 3 months compared with conventional BP management. These results suggest that intensive BP management should be avoided after successful EVT in acute ischemic stroke. Trial Registration: ClinicalTrials.gov Identifier: NCT04205305.

Indexed as

Antihypertensive AgentsBlood PressureFunctional StatusIschemic StrokeThrombectomyAcute DiseaseAgedCerebral HemorrhageEndovascular ProceduresFemaleHumansMaleStrokeTreatment OutcomeAntihypertensive Agents

Identifiers

PMID37668619
PMCPMC10481233
OpenAlexW4386439171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.